 |
|
|
| |
Benefit of continuous/immediate ART on disease risk: SMART & START combined analysis
|
| |
| |
Reported by Jules Levin
CROI 2017 Feb 14-16 Seattle WA
AH Borges1, J Neuhaus2, S Sharma2, J Neaton2, K Henry3, O Anagnostou4, T Staub5, S Emery6 and JD Lundgren1 for the INSIGHT SMART & START Study Groups
1CHIP, Dep Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 2Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA;
3Hennepin County Medical Center, Minneapolis, Minnesota, USA; 4University of Athens, Greece; 5Centre Hospitalier de Luxembourg, Service des Maladies Infectieuses, Luxembourg; 6Kirby Institute, Sydney, Australia
|
| |
|
|
|
|
|
